5 questions your patients need answered about the solar eclipse

Article

Our podcast with Omar Punjabi, MD, retinal specialist at Charlotte Eye, Ear, Nose, and Throat, discusses the science behind solar retinopathy and how eclipse glasses give protection that standard eyewear can’t.

Darryl Glover, OD, and Jennifer Lyerly, ODOn August 21, the skies over a 70-mile wide path from Oregon to South Carolina will darken as the sun is completely blocked by the moon in a rare total solar eclipse.

Americans haven’t had a chance to see such a cosmic event since 1979, and 500 million people across North America will experience at least a partial eclipse in action.

With such an historic occasion, viewing the eclipse is generating plenty of buzz and doing so safely is of utmost importance. 

Previously from Defocus Media: The next frontier: Mobile eyecare clinics

As optometrists, we are the point persons for our community’s concerns and questions about eye health and vision, and many of us will be fielding questions about how to view the eclipse safely as the day draws near.

Our podcast with Omar Punjabi, MD, retinal specialist at Charlotte Eye, Ear, Nose, and Throat, discusses the science behind solar retinopathy and how eclipse glasses give protection that standard eyewear can’t. He answers the top questions your patients will ask, and gives advice on how to best utilize the event for practice marketing.

Listen to more audio content from Defocus Media and Optometry Times here

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.